Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
Drug-induced TEN-like Conditions
Description
The presentation focuses on drug-induced conditions that resemble Toxic Epidermal Necrolysis (TEN). The speaker transitions from discussing Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) to exploring various TEN-like conditions, emphasizing the differential diagnosis in clinical practice. The segment highlights the similarities and differences in histopathology and clinical presentation among various drug-induced skin conditions, including Generalized Fixed Drug Eruption, Acute Generalized Exanthematous Pustulosis (AGEP), Methotrexate-Induced Epidermal Necrosis (MEN), Toxic Erythema of Chemotherapy (TEC), and immune checkpoint inhibitor-related skin eruptions. Each condition is characterized by its own unique presentation and potential consequences for patient health. The speaker underscores the importance of careful diagnosis and understanding of the mechanisms behind these conditions, as some can lead to severe systemic illness requiring intensive treatment. Recent cases of new drugs causing TEN-like symptoms are also discussed, showcasing the need for ongoing education in dermatological practice.
View moreConclusions
- Drug-induced TEN-like conditions can mimic classic TEN but often have different clinical and histopathological features.
- There are five main conditions that can present as drug-induced TEN-like reactions: generalized bullous fixed drug eruption, TEN-like AGEP, methotrexate-induced epidermal necrosis, toxic erythema of chemotherapy, and progressive immunotherapy-related mucocutaneous eruption (PIRME).
- Generalized bullous fixed drug eruption typically resolves with drug cessation and corticosteroid treatment, with a relatively favorable prognosis.
- TEN-like AGEP is characterized by massive dermal edema without epidermal necrosis, and while most cases do well, there are risks of severe systemic reactions in some patients.
- Methotrexate-induced epidermal necrosis involves true epidermal necrosis and can have serious systemic toxicity, necessitating immediate cessation of methotrexate and supportive care.
- Toxic erythema of chemotherapy is a self-limited reaction to various chemotherapeutic agents and has distinct histopathological features.
- PIRME, associated with immune checkpoint inhibitors, can present with lichenoid dermatitis and full-thickness epidermal necrosis, often requiring careful management of concomitant medications for a favorable outcome.
- Am J Clin Dermatol 2020 21(3):393
- Br J Dermatol 2013;168(4):726
- Int J Dermatol. 2022 Jun;61(6):707
- JAAD 2014;71(3):e89
- JEADV 2015;29(2):209
- Chen et al J Am Acad Dermatol 2017;77:247-5
- Am J Clin Dermatol 2022;23:449
- J Am Acad Dermatol 2021;85:956-66
- Front Med (Lausanne). 2022 Jun 13;9:898790
- Shi et al. Int J Dermatol 2023;62: 1211
- Birmingham et al. Am J Dermatopathol 2022;44:933-935